Showing 1 - 1 results of 1 for search 'Michael Schenker Group', query time: 0.03s
Refine Results
-
1
Four-year clinical update and treatment switching-adjusted outcomes with first-line nivolumab plus ipilimumab with chemotherapy for metastatic non-small cell lung cancer in the Che... by Enriqueta Felip, David P. Carbone, Martin Reck, Luis Paz-Ares, Yong Yuan, Nan Hu, Niels Reinmuth, Xiaoqing Zhang, Thomas John, Ying Cheng, Shun Lu, Manuel Cobo, Michael Schenker, Tudor-Eliade Ciuleanu, Stéphanie Bordenave, Oscar Juan-Vidal, Juliana Menezes, Eduardo Richardet, Hideaki Mizutani, Bogdan Zurawski, Aurelia Alexandru, Javed Mahmood, Tuli De, Irene Santi, John R. Penrod, Adam Lee
Published 2024-02-01
Article
Search Tools:
Refine Results
Page will reload when a filter is selected or excluded.- Adam Lee 1 results 1
- Aurelia Alexandru 1 results 1
- Bogdan Zurawski 1 results 1
- David P. Carbone 1 results 1
- Eduardo Richardet 1 results 1
- Enriqueta Felip 1 results 1
- Hideaki Mizutani 1 results 1
- Irene Santi 1 results 1
- Javed Mahmood 1 results 1
- John R. Penrod 1 results 1
- Juliana Menezes 1 results 1
- Luis Paz-Ares 1 results 1
- Manuel Cobo 1 results 1
- Martin Reck 1 results 1
- Michael Schenker 1 results 1
- Nan Hu 1 results 1
- Niels Reinmuth 1 results 1
- Oscar Juan-Vidal 1 results 1
- Shun Lu 1 results 1
- Stéphanie Bordenave 1 results 1
- Thomas John 1 results 1
- Tudor-Eliade Ciuleanu 1 results 1
- Tuli De 1 results 1
- Xiaoqing Zhang 1 results 1
- Ying Cheng 1 results 1
- Yong Yuan 1 results 1
- see all…